Stanford v. Roche Arguments Break Down Bayh-Dole Act | GenomeWeb

In arguments before the Supreme Court last month, Stanford University claimed that because its research that resulted in three PCR-based test kit patents — which the school alleges Roche Molecular Systems has infringed upon — was partly supported by federal funding, it has superior claim to title under the University and Small Business Patent Procedures Act, better known as the Bayh-Dole Act. Congress enacted Bayh-Dole in 1980 as an amendment to the Patent Act in an effort to protect the intellectual property interests of universities, small businesses, and non-profit organizations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.